Psilocybin safety and harm reduction

Compared with most psychoactive drugs, psilocybin is physically low in toxicity. But researchers who run psilocybin trials screen participants carefully, prepare them, and never leave them alone during a session, because the real risks are psychological and situational.¹ Outside a clinic, those safeguards are up to the people involved. This page covers what's known about the risks and what to do if something goes wrong.

Known risks

Difficult experiences

The most likely serious risk is overwhelming fear, confusion or distress during the experience, which can lead to dangerous behavior.¹ In the Global Drug Survey, anxiety, panic and paranoia were the most common reasons people who'd used magic mushrooms sought emergency care. Poor mindset, a poor setting and mixing substances were the reasons they gave most often.²

Impaired judgment and accidents

Poison centers list reduced awareness, agitation and confusion among the effects that lead to harm, including walking or driving unsafely.^3,4 Don't drive, swim or go near heights or traffic while under the influence.

Lasting visual changes (HPPD)

Some people report flashbacks or visual disturbances that persist after the drug wears off. When these are distressing and ongoing, the diagnosis is hallucinogen persisting perception disorder (HPPD). Reviews describe it as relatively rare, and many people who think they have it don't meet the diagnostic criteria.^1,5

Psychosis and mania

Clinical trials exclude people with a personal or family history of psychotic disorders, because psychedelics can trigger or worsen those conditions.¹ A 2025 meta-analysis estimated that psychedelic-induced psychosis is rare overall, but in uncontrolled studies that included people with schizophrenia, 3.8% developed long-lasting psychotic symptoms.⁶ In a large U.S. and U.K. study, psychedelic use was linked to more psychotic symptoms only among people with a personal or family history of bipolar disorder.⁷ A 2026 meta-analysis found mood switches into mania or hypomania were more likely with bipolar I disorder, family vulnerability, use of several drugs and unsupervised use.⁸

Heart and blood pressure

Psilocybin can raise heart rate and blood pressure, which may be dangerous for people with heart conditions.^4,9 Clinical trials suggest it's relatively safe for the heart in healthy volunteers, but there isn't enough evidence for people with cardiovascular disease.¹⁰

Who should avoid psilocybin

• People with a personal or family history of psychosis, schizophrenia or bipolar disorder. This is the clearest exclusion in research guidelines.^1,7
• People taking lithium. See the interactions table below.¹²
• People with heart conditions or high blood pressure.⁴
• People taking psychiatric medicines. Australia's Alcohol and Drug Foundation advises against it because the underlying condition could relapse or worsen. Don't stop a prescribed medicine on your own; talk to your prescriber.¹¹
• Anyone who'd be driving, working or responsible for others during or soon after the experience.³

Drug interactions

Most of what's known about psilocybin interactions comes from case reports, surveys and a handful of small studies. A 2024 systematic review found 52 studies of classic psychedelics combined with other drugs, 10 of them on psilocybin.¹⁵ The table below says how strong the evidence is for each combination.

Wild mushrooms and deadly lookalikes

The most dangerous lookalikes contain amatoxins, which cause about 95% of mushroom-poisoning deaths worldwide. Amatoxin species include Galerina marginata and Conocybe filaris.²⁰ Galerina marginata, the deadly galerina, grows on rotting wood, including urban wood chips, the same habitat as wood-loving Psilocybe species such as P. cyanescens. One difference is spore color: reddish brown for Galerina, dark purplish brown for Psilocybe.^21,22 That's a clue for experts, not a safe test for anyone else.

If you think someone has eaten a wild mushroom that might be poisonous, call Poison Control at 1-800-222-1222 right away. Don't wait for symptoms.^4,19

Shop-bought mushroom gummies and chocolates

Products sold as "mushroom" gummies and chocolates often don't contain what their labels say. In 2024, an FDA and CDC investigation of illnesses tied mainly to Diamond Shruumz-brand products counted 180 illnesses in 34 states, 73 hospitalizations and three potentially associated deaths. FDA testing found compounds such as muscimol, pregabalin and kavalactones in various products.²³ A 2025 study of 12 edibles (11 gummies and a chocolate bar) bought in Portland, Oregon, found psilocybin in none of them; some contained psilocin or synthetic tryptamines, and others contained caffeine, cannabinoids or nothing active at all.²⁴ Our guide to reading a lab report explains what a real test result should show.

Set and setting

"Set" means a person's mindset, expectations and intentions; "setting" means the physical and social environment. Both strongly shape how a psychedelic experience goes.²⁵ In clinical research, the safeguards are careful preparation, a safe and comfortable space, and a trusted person present throughout.¹ The reasons people gave for emergency visits in the Global Drug Survey, a poor mindset, a poor setting and mixing drugs, are the mirror image of those safeguards.²

What to do in an emergency

For support during or after a difficult psychedelic experience that isn't an emergency, the Fireside Project runs a free peer support line: call or text 62-FIRESIDE (623-473-7433), 11 a.m. to 11 p.m. Pacific, every day. It says plainly that it isn't a suicide hotline or a clinical service, and it directs emergencies to 911 and suicidal thoughts to 988.²⁹ For treatment referrals and information about substance use, SAMHSA's National Helpline is free and open 24/7 at 1-800-662-4357.³⁰

More organizations are listed on our help and resources page.